Antibodies to brush-border antigens in ankylosing spondylitis
Hrncír, Z.; Nozicka, Z.; Bradna, P.
Casopis Lekaru Ceskych 127(3): 84-85
1988
ISSN/ISBN: 0008-7335 PMID: 3258190 Document Number: 312424
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Sany, J.; Panis, G.; Seignalet, J.; Serre, H. 1979: Ankylosing spondylitis without HL-A B27 antigens La Nouvelle Presse Medicale 8(44): 3663-3664
Bale, U.M.; Mehta, M.M.; Contractor, N.M.; Bhatia, H.M.; Tilve, G.H. 1980: HLA antigens in ankylosing spondylitis: the association of HLA-B27 Indian Journal of Medical Research 71: 96-103
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Russell, A.S.; Schlaut, J.; Percy, J.S.; Dossetor, J.B. 1974: HL-A (transplantation) antigens in ankylosing spondylitis and Crohn's disease Journal of Rheumatology 1(2): 203-209
Prohaska, E.; Neumüller, J.; Partsch, G.; Eberl, R. 1980: Antinuclear antibodies in ankylosing spondylitis Wiener Klinische Wochenschrift 92(24): 876-879
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Kaji, T.; Yano, S.; Nojima, Y.; Naruse, T. 1999: Role of autoantibodies against tubular brush border antigens in tubulointerstitial nephritis associated with Heymann nephritis Research Communications in Molecular Pathology and Pharmacology 104(1): 53-62
Barabas, A.Z.; Cornish, J.; Lannigan, R. 1985: Progressive passive Heymann nephritis: induction of autologous antibodies to rat brush border by multiple injections of heterologous antiserum Clinical and Experimental Immunology 60(2): 381-386
Yuan, G.; Shi, G.; Ding, Y. 1995: Serum anti-subtypical Klebsiella pneumoniae antibodies in ankylosing spondylitis Zhonghua Nei Ke Za Zhi 34(3): 193-195
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Chen, C.S.; Shi, G.Y. 1994: Detection of serum anti-histone antibodies in patients with ankylosing spondylitis and its clinical significance Zhonghua Nei Ke Za Zhi 33(6): 382-384
Appel, H.; Scheer, R.; Haibel, H.; Wu, P.; Spiller, I.; Brandt, H.; Song, I-Ho.; Rudwaleit, M.; Thiel, A.; Sieper, J. 2007: In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis Journal of Rheumatology 34(11): 2264-2270
Domínguez-López, M.L.; Ortega-Ortega, Y.; Manríquez-Raya, J.C.; Burgos-Vargas, R.; Vega-López, A.; García-Latorre, E. 2009: Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients Clinical and Experimental Rheumatology 27(4): 626-632
Mäki-Ikola, O.; Lehtinen, K.; Toivanen, P.; Granfors, K. 1995: Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis British Journal of Rheumatology 34(5): 418-420
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Giudicelli, J.; Rigat, A.M.; Sudaka, P. 1975: Electrofocusing of hydrolases in rat brush border enterocytes Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(2): 372-379
Kocna, P.; Fric, P.; Slabý, J.; Kasafírek, E. 1978: Endopeptidase isolation in rat enterocyte brush border Casopis Lekaru Ceskych 117(40): 1258-1261